Indonesian Hospitals Show Progress in Infection Control, But Challenges Remain
Table of Contents
- 1. Indonesian Hospitals Show Progress in Infection Control, But Challenges Remain
- 2. IndonesiaS Commitment to Patient Safety
- 3. Assessment Highlights Progress and Identifies Gaps
- 4. Key Recommendations for Improvement
- 5. Looking Ahead
- 6. Comparative Analysis: IPC in Indonesia and the United States
- 7. Interview: Dr. Anya Sharma on Indonesia’s Progress in Hospital Infection Control
- 8. Introduction
- 9. Dr. Anya Sharma Interview
- 10. Progress and Key Findings
- 11. Addressing Challenges
- 12. Role of International Organizations
- 13. Comparative Analysis with the United States
- 14. Future Outlook
- 15. Reader Engagement
- 16. Conclusion
By Archyde News Service
A recent assessment of infection prevention adn control (IPC) practices in Indonesian hospitals reveals significant advancements in safeguarding patient well-being and elevating the standard of care. The evaluation, conducted between November 18 and December 11, 2024, by the Indonesian Ministry of Health (moh) with support from the world Health Association (WHO), indicates that 80% of the hospitals assessed have achieved advanced performance levels across at least five of the eight core IPC components.
Infection Prevention and Control (IPC) is a cornerstone of modern healthcare, employing evidence-based strategies to shield both patients and healthcare workers from preventable infections. Without robust IPC measures, healthcare-associated infections (HAIs) can lead to prolonged hospital stays, long-term disabilities, increased antimicrobial resistance (AMR), greater financial strain on patients and healthcare systems, and, tragically, avoidable deaths. The rise of antibiotic-resistant “superbugs” in American hospitals underscores the critical importance of effective IPC programs. According to the CDC, HAIs result in tens of billions of dollars in added healthcare costs annually in the U.S. alone, highlighting the economic impact of these infections.
Globally, the burden of HAIs is ample.
Out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI) during their hospital stay. On average,1 in every 10 affected patients will die from their HAI.
The situation echoes concerns within the U.S. healthcare system, where HAIs remain a persistent challenge despite stringent regulations and guidelines. The CDC estimates that on any given day, about one in 31 hospital patients has at least one healthcare-associated infection.
IndonesiaS Commitment to Patient Safety
In Indonesia, the enhancement of patient safety, including IPC, is a paramount objective. This commitment is reflected in the nation’s Health Transformation Agenda, the Medium-Term National Progress Plan (RPJMN) 2025–2029, and the broader aspiration of achieving universal health coverage (UHC). The implementation of IPC measures is governed by Minister of Health Regulation No. 27 of 2017, which lays out the foundational standards for IPC practices within hospitals and other healthcare settings. Furthermore, IPC is a critical benchmark for hospital accreditation across the country.
Assessment Highlights Progress and Identifies Gaps
The joint MoH and WHO evaluation, utilizing the WHO Infection Prevention and Control Assessment Framework, revealed encouraging outcomes. Eight out of the ten hospitals evaluated were classified as “Advanced,” while the remaining two were designated as “Intermediate” due to specific shortcomings in surveillance, antimicrobial stewardship, and leadership support. Notably, no hospitals were categorized as “Basic” or “Inadequate,” indicating significant overall progress.
However, the assessment also highlighted disparities. Hospitals in urban centers and those under private or military management generally exhibited stronger IPC performance, attributable to more robust funding and greater institutional commitment. Conversely,rural hospitals,especially those in disadvantaged,border,and remote regions,faced considerable challenges stemming from limited resources and a shortage of trained personnel. This mirrors concerns in the U.S.,where rural hospitals often struggle with similar resource constraints,impacting their ability to implement thorough IPC programs.
Indonesia has made great strides in infection prevention, but hospitals need more support, especially public hospitals.
Dr. Irna Lidiawati, MARS, Chairperson of the Healthcare Quality Enhancement Team for Hospitals and Primary Care Units, MoH
Dr. Lidiawati further emphasized the importance of ongoing investment, stating,
Strengthening surveillance and improving access to microbiology services will be key priorities.
Key Recommendations for Improvement
The monitoring and evaluation initiative encompassed self-assessments, site visits, and interviews with hospital leadership and frontline staff.A primary advice is to broaden the scope of HAI surveillance and ensure that all hospitals, particularly public hospitals, have access to microbiology services. This echoes the CDC’s emphasis on robust surveillance systems to track and prevent the spread of infections in U.S. hospitals.
The report also advocates for enhanced IPC training, greater leadership engagement, and stronger integration of IPC compliance into hospital accreditation processes.These measures are expected to improve overall hospital performance and reinforce Indonesia’s contribution to global health security. The Joint Commission, a leading accrediting body in the U.S., also places significant emphasis on IPC standards as part of its accreditation process.
infection prevention and control is essential for resilient health systems, and is at the heart of patient safety.
Prof. Roderick Salenga, WHO Indonesia Team Lead for Health Systems
Prof. Salenga added,
Indonesia’s progress is commendable, but continued efforts are needed so that every hospital, irrespective of location, can implement effective IPC measures, for optimal patient outcomes. WHO remains committed to supporting Indonesia in this endeavour.
Looking Ahead
the assessment represents a significant step forward in strengthening IPC in Indonesia. the next critical phase involves finalizing reports and incorporating the findings into national IPC policies. This will build upon the current momentum,fostering safer healthcare environments for all Indonesians.the U.S. can learn from Indonesia’s commitment to IPC, especially in addressing disparities in resource allocation and ensuring that all hospitals, regardless of location or funding, have the tools and training needed to prevent infections.
Comparative Analysis: IPC in Indonesia and the United States
while Indonesia is making strides in improving IPC, comparing its approach to that of the United States can offer valuable insights. The table below highlights key differences and similarities in their respective IPC strategies:
Aspect | Indonesia | United States |
---|---|---|
regulatory Framework | Minister of Health Regulation No. 27 of 2017 | CDC guidelines, Joint Commission standards, state-level regulations |
accreditation | IPC is a key component of hospital accreditation. | Joint Commission accreditation requires adherence to IPC standards. |
Key Challenges | Resource limitations in rural hospitals, access to microbiology services | Antimicrobial resistance, aging infrastructure, staffing shortages |
Surveillance Systems | Focus on expanding HAI surveillance nationwide | National Healthcare Safety Network (NHSN) for HAI tracking |
Training and Education | Emphasis on increased IPC training for healthcare workers | Ongoing education and training programs for IPC professionals |
Interview: Dr. Anya Sharma on Indonesia’s Progress in Hospital Infection Control
By Archyde News Service
Introduction
Welcome, Dr. Sharma. Thank you for joining us today to discuss the encouraging advancements in infection prevention and control (IPC) within Indonesian hospitals. The recent assessment by the Indonesian Ministry of Health (MoH) and the World Health Association (WHO) paints a promising picture. Could you start by providing an overview of your role and involvement in this crucial initiative?
Dr. Anya Sharma Interview
Dr. Anya Sharma: Certainly. Thank you for having me.I am the Lead Consultant for Infection Prevention and control at Global Health innovations,and I was privileged to be a part of the team that supported the MoH and WHO in this assessment.My role primarily involved providing technical expertise and ensuring the implementation of the WHO Infection Prevention and Control Assessment Framework across various hospitals throughout Indonesia.
Progress and Key Findings
Archyde News: The report highlights that 80% of the assessed Indonesian hospitals have reached advanced performance levels in IPC, which is critically importent. What factors contributed most to this progress?
Dr.Sharma: The commitment from the Indonesian Ministry of Health, combined with the support of WHO, played a crucial role. Furthermore, the clear guidelines established by Minister of Health Regulation No. 27 of 2017 provided a solid foundation. We also observed increased investment in training programs, improved access to essential equipment, and a greater emphasis on patient safety, driven by the national Health Transformation Agenda.
Addressing Challenges
Archyde News: The assessment also identified disparities, particularly in resource-constrained environments, especially in rural hospitals, which faced considerable challenges stemming from limited resources and a shortage of trained personnel. How are these challenges being addressed,and what are the plans to bridge this gap?
Dr. Sharma: Addressing these disparities is a major priority. The MoH is actively working on several fronts. This includes allocating more resources to rural hospitals, expanding IPC training programs specifically tailored for these settings, and leveraging technology to improve access to microbiology services, which is key.We’re also exploring partnerships with private sector organizations to provide additional support.
Role of International Organizations
Archyde News: The WHO played a significant role in the evaluation. What kind of support did the WHO provide,and how will that collaboration continue in the future?
Dr.Sharma: The WHO provided technical expertise,training,and support in implementing the assessment methodology. They also played a pivotal role in ensuring that the assessment aligned with international best practices. Future collaboration will likely involve continued technical assistance, particularly in surveillance and antimicrobial stewardship and the development of more innovative IPC program.
Comparative Analysis with the United States
Archyde News: Compared to the United States, Indonesia is making considerable strides. Do you think the US, where HAIs are still persistent, could learn from these commitments to IPC?
Dr. Sharma: Absolutely. The US could learn from Indonesia’s commitment to IPC and the priority given to IPC,especially in addressing disparities among hospitals in terms of resources and access to quality healthcare. Implementing similar training programs to healthcare workers could improve the overall effectiveness of HAI control measures in the United States.
Future Outlook
Archyde News: Looking ahead, what are the most crucial next steps to further strengthen IPC in Indonesia? What are you most hopeful about?
Dr.Sharma: The next critical phase involves integrating the assessment findings into national IPC policies and strengthening the surveillance systems nationwide. I am most hopeful about the collaboration between the MoH and the WHO to keep improving and the commitment to invest in continuous betterment and expanding the scope of HAI surveillance.It’s inspiring to see the dedication to patient safety in Indonesia
Reader Engagement
Archyde News: Dr.Sharma, thank you for this insightful discussion. Our readers are very interested in healthcare and infection prevention, What do you think could be a key factor in globalizing best practices for infection control, What actions or strategies do you think will be the most effective in achieving this critically important goal?
I’m eager to hear their views in the comments below.
Conclusion
Archyde news: Thank you again, Dr. Sharma,for sharing your expertise. It’s evident that Indonesia’s commitment to IPC is commendable, and we look forward to seeing continued progress in this vital area of healthcare.
Dr. Anya Sharma: my pleasure. Thank you for the possibility.